Anticoagulants Market Rising at 7.5%CAGR to 2025: Analysis of Key Players, Trends, Drivers, & Challenges

The global anticoagulants market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025. Anticoagulants, commonly known as blood thinners, are chemical substances that prevent or reduce coagulation of blood and prolong the clotting time. The market has different […]

Read More

Anticoagulants Market to Register Steady Expansion 2025

Anticoagulants are utilized to take out the danger of blood clumps in the body. Anticoagulants prevent the platelets from clinging to each other and coagulating proteins from restricting together. These are usually utilized in the treatment of DVT (deep vein thrombosis), atrial fibrillation, pneumonic embolism as well as managing moderate and high danger of stroke. Anticoagulants […]

Read More

Anticoagulants Market will Reach at a CAGR of 8.0% from 2018-2026

Anticoagulants Market – Snapshot Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists, DTIs, and factor Xa inhibitors, are among the various anticoagulants available in the market. These are used for indications such as heart attack, […]

Read More

Anticoagulants Market is Anticipated to Reach US Dollar 39 Billion by 2026 | CAGR at 7.9%

 The international Anticoagulants market is prophesied to grow with 7.9% CAGR between the year 2018 to 2026 and the market is expected to hit the value of USD 39 billion by 2026. Increasing surgeries and heart related diseases is foreseen to drive the demand for anticoagulants over forecast period. Other factors such as, the global increase in […]

Read More

Anticoagulants Market Detail Analysis, Focusing on Top Players: Bristol-Myers Squibb Company, Pfizer, Inc., Bayer Healthcare, Pfizer, Inc., ohnson & Johnson Services and Others

Recent study titled, “Anticoagulants Market (By Route of Administration: Oral , Injectable; By Drug Class: Factor XA Inhibitors (NOAC/DOAC), Heparins, Direct Thrombin Inhibitors, Vitamin K Antagonists; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; By Indication: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Atrial Fibrillation, Heart Attack) – Global Industry Analysis, Market Size, Opportunities […]

Read More

Anticoagulants Market to Grow at a CAGR of 8.0% through 2026

Anticoagulants Market – Snapshot Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists, DTIs, and factor Xa inhibitors, are among the various anticoagulants available in the market. These are used for indications such as heart attack, […]

Read More